文献速递头颈外科咽喉与嗓音

喉癌治疗后慢性阿片类药物使用:VA研究

Chronic Opioid Use after Laryngeal Cancer Treatment: A VA Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-02-25

该回顾性队列研究纳入2005至2015年间单中心VA医疗系统中74例新诊断并接受治疗的喉癌退伍军人,分析阿片类药物使用情况。结果显示,诊断前已使用阿片类药物者90天持续使用风险高10倍、360天慢性使用风险高8倍,诊断后1年内最大MME与慢性使用显著相关。

要点

  • 诊断前已有阿片使用使90天持续使用风险升高10倍
  • 诊断前阿片使用使360天慢性使用风险升高8倍
  • 1年内最大MME与90天及360天慢性使用显著相关

核心结论

  • 诊断前已有阿片类药物使用及最大MME与喉癌退伍军人慢性阿片使用强烈相关,且独立于分期和治疗方式。

研究设计与样本

  • 单中心退伍军人健康管理局的回顾性队列研究,纳入2005至2015年新诊断并治疗的74例活检证实的喉癌退伍军人。

主要发现

  • 诊断前超过30天使用阿片者90天持续使用可能性高10倍(P = .0024),360天慢性使用可能性高8倍(P = .0041)。
  • 诊断后1年内最大MME与90天慢性使用(P = .00045)及360天慢性使用(P = .0006)显著相关。

临床怎么用

  • 喉癌治疗前应评估既有阿片使用史,对诊断前已用阿片者加强随访与疼痛管理,关注最大MME以识别慢性使用高危患者。

局限性

  • 单中心VA站点、样本量小(74例)且以男性白人为主,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate opioid utilization in veterans undergoing laryngeal cancer treatment and describe the risk of chronic use after treatment cessation. STUDY DESIGN: A retrospective cohort study. SETTING: A single Veterans Health Administration site. SUBJECTS AND METHODS: Veterans with newly diagnosed and treated laryngeal cancer with attributable opioid use from 2005 to 2015. Milligram morphine equivalents (MMEs) were calculated from 90 days prior to diagnosis for up to 1 year. Adjuvant pain medications filled 30 days prior to and up to a year from the date of diagnosis were assessed. RESULTS: Of 74 veterans with biopsy-proven laryngeal carcinoma, 73 (98.6%) were male and 71 (96%) were white. Forty-three (58%) patients were stage 0/I/II; 31 (42%) were III/IV. Eleven (14.9%) were treated with surgery alone, 35 (47.3%) with radiation alone, and 28 (38%) with multimodal therapy. Twenty-four (32.4%) patients had preexisting opioid use prior to cancer diagnosis. Patients who used opioids more than 30 days prior to date of diagnosis were found to be 10 times more likely to have persistent opioid use at 90 days (P = .0024) and 8 times more likely to have chronic use at 360 days (P = .0041). Maximum MMEs within 1 year of diagnosis were significantly associated with chronic use at 90 days (P = .00045) and chronic use at 360 days (P = .0006). CONCLUSION: Preexisting opioid use and maximum MMEs are strongly associated with chronic opioid use among veterans treated for laryngeal carcinoma independent of stage and treatment type.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Craker NC, Gal TJ, Wells L, et al. Chronic Opioid Use after Laryngeal Cancer Treatment: A VA Study. Otolaryngol Head Neck Surg. 2020. PMID: 32093569. doi:10.1177/0194599820904693

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。